marinedrugs-logo

Journal Browser

Journal Browser

Selected Papers from the 2025 Symposium on Marine Microbiology in China

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 31 January 2026 | Viewed by 532

Special Issue Editors


E-Mail Website
Guest Editor
Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou 510301, China
Interests: marine natural product chemistry; drug leads; pharmacological mechanism; marine microorganisms; biotransformation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
State Key Laboratory of Tropical Oceanography, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou 510301, China
Interests: marine actinobacterial resources; hydrolase enzymes, and their applications
State Key Laboratory of Tropical Oceanography, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou 510301, China
Interests: toxin–antitoxin systems; environmental adaptation; mobile genetic elements
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The "2025 Symposium on Marine Microbiology in China" is jointly organized by the South China Sea Institute of Oceanology, the Chinese Academy of Sciences and the Marine Microbiology Professional Committee of the Chinese Society for Microbiology and will be held in Guangzhou from August 27 to 30, 2025.

With the theme of "Frontier Exploration and Application Innovation of Marine Microorganisms", this symposium aims to garner well-known scholars in China and abroad to share their cutting-edge research findings. Its objective is to showcase the latest achievements and progress in the field of marine microbiology, explore the opportunities and challenges its faces, and clarify key research directions for the future. It additionally seeks to promote collaboration and joint innovation between marine microbiology and other disciplines and boost the high-level development of China's marine microbiology research and blue marine industry.

The organizing committee would like to invite experts, scholars and graduate students engaged in marine microbiology and related fields to come to Guangzhou and participate in this significant event.

We welcome submissions from participants of the conference and global researchers who are interested in its subject matter. Research submitted to this Special Issue should pertain to the following themes:

  1. Medicinal marine environmental resources;
  2. Bioactive compounds from marine microorganisms;
  3. Toxin–antitoxin systems in marine microorganisms;
  4. Marine microbial metabolism and biosynthesis;
  5. Research on marine biomedicine products;
  6. Chemical ecology research inspiring marine drug discovery;
  7. Marine biotechnology and molecular biology studies related to drug discovery;
  8. New technologies and methods in marine natural products;
  9. Artificial intelligence in marine drug research

Prof. Dr. Xuefeng Zhou
Prof. Dr. Xinpeng Tian
Dr. Yunxue Guo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine microorganisms
  • marine natural products
  • marine toxins
  • biosynthesis
  • chemical ecology
  • marine biotechnology
  • molecular biology
  • artificial intelligence

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 3752 KB  
Article
Discovery of a Hepatoprotective Trinor-Sesterterpenoid from the Marine Fungus Talaromyces sp. Against Hepatic Ischemia-Reperfusion Injury
by Wenxun Lan, Jian Cai, Liyan Yan, Xinyi Wu, Lisha Zhang, Chunmei Chen, Zhongqiu Liu, Xuefeng Zhou and Lan Tang
Mar. Drugs 2025, 23(8), 329; https://doi.org/10.3390/md23080329 - 16 Aug 2025
Viewed by 391
Abstract
A new trinor-sesterterpenoid penitalarin D (1), with a 3,6-dioxabicyclo[3.1.0]hexane moiety, as well as two known compounds, penitalarin C (2) and nafuredin A (3), were obtained from the mangrove sediment-derived Talaromyces sp. SCSIO 41412. Their structures were determined [...] Read more.
A new trinor-sesterterpenoid penitalarin D (1), with a 3,6-dioxabicyclo[3.1.0]hexane moiety, as well as two known compounds, penitalarin C (2) and nafuredin A (3), were obtained from the mangrove sediment-derived Talaromyces sp. SCSIO 41412. Their structures were determined by detailed NMR, MS spectroscopic analyses, and ECD calculations. Penitalarin D (1) and nafuredin A (3) showed toxicity or no toxicity against HepG2 cells at a concentration of 200 μM. The transcriptome sequencing and bioinformatics analysis revealed that 3 could be effective by regulating ferroptosis pathways in HepG2 cells, which was subsequently validated by RT-qPCR, demonstrating significant upregulation of ferroptosis-related genes. Pre-treatment with 3 could mitigate hypoxia-reoxygenation-induced damage in the oxygen glucose deprivation/reperfusion (OGD/R) cell model. Given the structural similarity of compounds 1, 2, and 3, we also screened compounds 1 and 2 in an AML12 OGD/R model. As no significant activity was observed, compound 3 was selected for subsequent in vivo studies. Subsequently, in vivo experiments demonstrated that 3 could significantly decrease pro-inflammatory cytokines and display the hepatoprotective effects against hepatic ischemia-reperfusion injury (HIRI). These findings identified nafuredin A (3) as a promising hepatoprotective agent for new drug development. Full article
Show Figures

Figure 1

Back to TopTop